Crescent Biopharma
CBIO
#6974
Rank
$0.74 B
Marketcap
$19.99
Share price
-2.30%
Change (1 day)
N/A
Change (1 year)

Revenue for Crescent Biopharma (CBIO)

Revenue in 2026 (TTM): $11.88 Million USD

According to Crescent Biopharma's latest financial reports the company's current revenue (TTM ) is $11.88 Million USD. In 2025 the company made a revenue of $10.84 Million USD.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Crescent Biopharma from 2025 to 2026

Annual revenue

Year Revenue Change
2026 (TTM) $11.88 M9.58%
2025 $10.84 M